Nitrous Oxide

Quick links to important sections

Nitrous Oxide

Selected form

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nitrous Oxide

Quick Facts

Property Description
Active ingredient Nitrous Oxide (N₂O)
Form Compressed Gas, Medical Gas
Pharmacological Class General Anesthetic, Analgesic Agent
Common Use Sedation and Pain Relief
Origin Synthetic, Inorganic Compound

What Type of Medicine is Nitrous Oxide?

Nitrous Oxide is classified primarily as a General Anesthetic and a potent Analgesic Agent (pain reliever) utilized in controlled medical settings. It is a synthetic, inorganic compound with the chemical formula N2O, recognized globally under its official nomenclature, dinitrogen monoxide. It is recognized as an Essential Medicine, highlighting its importance in health systems worldwide. This regulatory recognition confirms its importance for medical procedures that require managing pain and anxiety. Nitrous oxide produces rapid, reversible effects on the central nervous system. As an International Nonproprietary Name (INN), Nitrous Oxide is the active component in several commercial medical gas mixtures, such as Entonox and Nitronox.


Form and Composition of Medical Gas

The pharmaceutical preparation of the drug is a Compressed Gas, administered exclusively via the Inhalational Route. The active ingredient is the single-entity compound Nitrous Oxide, which functions as a pure medical gas. For safety and clinical effectiveness, it is universally delivered in a regulated mixture alongside Oxygen as a gaseous vehicle and carrier, ensuring the patient receives an adequate amount of oxygen during sedation. Nitrous Oxide provides rapid pain relief across various clinical environments. This indicates that the gas is a fast and effective tool for easing temporary discomfort. This controlled, gaseous format allows for exceptional precision in managing the patient's level of sedation and for immediate discontinuation of the agent when the procedure is complete, a feature that differentiates it from many long-acting intravenous sedatives.

Regulatory References

  1. World Health Organization (WHO) Essential Medicines Lists
  2. Nitrous oxide entry on the WHO Electronic Essential Medicines List
  3. NCBI Bookshelf article 'Nitrous Oxide' in StatPearls

What side effects are possible with Nitrous Oxide?

Possible Side Effects and Safety Information

This information describes the documented adverse reactions and safety restrictions for Nitrous Oxide as defined by government regulatory agencies.

Adverse Reactions by Frequency and System

Adverse reactions are classified by how often they may occur (frequency) and by the body system affected (System-Organ Class).

  • Nervous System Disorders: Common effects can include dizziness or headache. Serious, long-term effects like neurological damage, paralysis, limb weakness, or psychiatric disturbances are documented, particularly following prolonged or repeated exposure/misuse.
  • Blood and Lymphatic System Disorders: Nitrous Oxide can affect the metabolism of Vitamin B12 and folate. This can lead to abnormal blood counts (myelosuppression) and, with long-term exposure, severe neurological effects.
  • Gastrointestinal Disorders: Nausea and vomiting are commonly reported, especially after longer procedures.
  • Cardiac and Vascular Disorders: Potential for changes in blood pressure, heart rate, and very rarely, blood clots.

Serious Safety Restrictions and Contraindications

Serious Adverse Reactions documented in regulatory sources include death, severe asphyxiation, blood clots, and irreversible spinal cord or brain damage (related to misuse or prolonged exposure).

Use is contraindicated and must be avoided in patients with conditions where the expansion of gas-filled spaces in the body is hazardous, such as pneumothorax, pulmonary bullae, or acute head injury.

Population-Specific and Exposure-Related Safety

  • Pregnancy: The gas is not recommended for use during the first trimester of pregnancy due to the documented potential for developmental toxicity related to its impact on folate metabolism.
  • Exposure Duration: The official safety profile explicitly links prolonged or repeated exposure to the most serious outcomes, including neurotoxicity and severe Vitamin B12 deficiency. Postoperative Nausea and Vomiting (PONV) is noted as more common after administrations lasting over two hours.

Overdose and Emergency Response

Overdose Manifestations and Urgent Action

Overdose of Nitrous Oxide presents primarily through two types of risk as documented in regulatory information. Acute overexposure can lead to rapid signs of drowsiness or dizziness, escalating to loss of consciousness or rapid suffocation (asphyxiation) due to the displacement of necessary oxygen. In any instance of overexposure resulting in these signs, or if the individual feels unwell, a poison center or doctor should be called immediately. The first required action is to remove the victim to fresh air and keep them at rest.

Severe Outcomes and Monitoring

More severe outcomes associated with prolonged or repeated exposure are classified as neurological and hematological toxicities due to functional Vitamin B12 deficiency. Documented complications include Spinal Cord Damage, Megaloblastic Anemia, and severe psychiatric disturbances. Hospital admission is required if a patient is unable to walk independently or exhibits evidence of these severe hematological or psychiatric sequelae. Management often requires close clinical supervision and haematological monitoring. Patients with an undiagnosed subclinical Vitamin B12 deficiency are identified as a population at higher risk for these severe effects.

Local Injury and Supportive Care

Direct contact with the compressed gas can cause a local injury known as frostbite. For this injury, immediate medical advice must be sought, and the affected area must be thawed with lukewarm water without rubbing. No specific chemical antidote is documented to reverse the immediate effects. Supportive management includes the use of Vitamin B12 substitution therapy when chronic toxicity is suspected.

Therapeutic Uses of Nitrous Oxide

What Nitrous Oxide Treats: Main Uses and Benefits

The therapeutic application of Nitrous Oxide focuses on supportive symptom management, particularly in conditions associated with acute or disruptive episodes. This agent is commonly used to help with analgesia (pain relief) and conscious sedation during short, painful, or distressing interventions. The support it provides may help patients cope more steadily when symptoms related to physical discomfort intensify and is applied across therapeutic domains including dental procedures, labor analgesia (managing pain during childbirth), and emergency interventions.

Its primary role is generally to support a state of relaxation and ease, where the patient remains responsive but relaxed. It is used for managing emotional symptoms like anxiety and fear, and helps address symptom clusters that may become intense or disruptive, supporting the patient during difficult episodes by easing distress.


Quick Fact: Support for Acute Symptom Manifestations

Symptom Focus Application Primary Benefit
Acute Procedural Pain Short-duration, invasive treatments May contribute to easing the overall symptom load
Anxiety and Fear Pre-intervention distress May support general well-being during symptomatic phases
Hyperactive Reflexes Functional strain May assist with maintaining functional stability

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Nitrous Oxide — official regulatory information

Populations for whom use is allowed (as stated in label): Generally permitted for use as an analgesic and anesthetic adjunct when medically necessary and when no contraindications exist.

Populations for whom use is contraindicated (Must Not Use):

  • Conditions with Trapped Gas: The drug is prohibited in the presence of air or gas-filled spaces where expansion would be dangerous, including pneumothorax (collapsed lung), air embolism, bullous emphysema, or following recent retinal surgery (if an intraocular gas bubble is present).
  • Vitamin B12 Deficiency: Contraindicated for individuals with a known or suspected deficiency of Vitamin B12 or folate due to the risk of irreversible neurological and hematological damage.
  • Impaired Consciousness: Contraindicated in patients with an altered mental status or an inability to comply with instructions (such as breathing through a nasal mask).
  • Age: Use in neonates is generally not recommended.

Eligibility-related restrictions: Prolonged or frequent administration of Nitrous Oxide should be closely monitored for signs of myeloneuropathy and megaloblastic changes. Caution is also advised in patients with chronic obstructive pulmonary disease (COPD) or low blood pressure.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for this medicinal gas is defined by specific pharmacodynamic and substance-related effects documented in regulatory labeling.

Documented Interaction Patterns

Co-administration with Central Nervous System (CNS) Depressants (including opioids, benzodiazepines, and alcohol) results in an additive CNS depressant effect, increasing the risk or severity of sedation and potential effects on respiration. The same additive anesthetic effect is observed when used with other General Anesthetics, formally requiring a reduced dose of the co-administered agent. Co-use with Methemoglobin-Inducing Substances may also lead to an increased risk of methemoglobinemia.

Substance and Timing Restrictions

A key functional interaction is the irreversible inactivation of Vitamin B12, which interferes with folate metabolism. To mitigate this risk, regulatory guidance establishes limits on the duration and frequency of administration (e.g., a maximum of 24 continuous hours). The interaction risk is heightened in specific populations, such as those with known or subclinical deficiency of Vitamin B12 or Folic Acid.

Co-administration is contraindicated in the presence of Intraocular Gas Injections (e.g., SF6 or C3 F8) due to the physical risk of severe increased intraocular pressure from gas expansion. Some regulatory authorities also advise against co-administration with Methotrexate due to the potential for potentiated cytotoxicity from altered folate pathways.

Mechanism of Action

Nitrous oxide left( N2 O ight) is a gaseous agent that rapidly diffuses across biological membranes, primarily targeting the Central Nervous System.

Its main molecular interaction involves N-methyl-D-aspartate (NMDA) receptors, where it functions as a non-competitive antagonist to inhibit ionotropic currents mediated by the excitatory neurotransmitter glutamate. This inhibition of the NMDA receptor-mediated calcium ion left( Ca^2+ ight) influx leads to a general reduction in neuronal excitability within the brain and spinal cord, contributing to the anesthetic component.

In addition, N2 O acts as a positive allosteric modulator of GABA A and glycine receptors, enhancing the inhibitory currents mediated by gamma-aminobutyric acid (GABA) and glycine, respectively. This modulation contributes to the anxiolytic and sedative effects.

The analgesic mechanism involves the endogenous opioid system. N2 O modulates the activity of brainstem noradrenergic neurons, resulting in the release of endogenous opioid peptides, particularly in the midbrain. These released peptides act as agonists at opioid receptors left( chiefly kappa and possibly mu ight) in the spinal cord, activating the descending noradrenergic inhibitory pathway to suppress nociceptive signaling. System-level physiological consequences include reduced neural transmission and generalized central depression of sensory processing.

Dosage and Administration Information

Nitrous Oxide is supplied as a Compressed Gas and is intended exclusively for respiratory administration (inhalation). Due to its nature as an anesthetic and analgesic agent, its use is governed by a precise clinical protocol. The most essential usage instruction is that the gas must be administered only by or under the supervision of a licensed practitioner experienced in the use of inhalational agents and in the management of patient response.

Usage is characterized as acute and procedural, meaning the medicine is applied intermittently and only for the short duration of the required intervention, not as a long-term or scheduled daily therapy. A critical step in the preparation and use protocol is the requirement that the pure gas must be delivered after being diluted with other designated medical gases, such as Oxygen (O₂), ensuring a safe, physiologically acceptable mixture is inhaled.

Dosing is not predetermined by a fixed schedule; instead, the practitioner titrates the concentration of the gas mixture individually to the patient's immediate clinical need and observed response. This titration principle applies across all age groups, including pediatric patients. Following the discontinuation of the Nitrous Oxide supply, the overall procedural protocol may include administering 100% Oxygen for a short duration to ensure proper clearance of the agent from the body. Clinical protocols define the standardized, highly controlled clinical approach for its use.

Recent Clinical Evidence

Research evidence / Overview of studies for Nitrous Oxide


Evidence for Use in Labor Analgesia

Research has explored outcomes related to physical discomfort during childbirth in studies primarily based on Randomized Controlled Trials (RCTs) and broad Systematic Reviews. These studies focused on maternal-reported labor pain scores, patient satisfaction, and tracked obstetric outcomes in study populations consisting of pregnant women intending a vaginal birth.

Studies describe that the measured pain scores observed in trials were often described as having a restricted measurement range when evaluated against established methods, such as regional analgesia. Findings describe patterns related to patient satisfaction and perceived control during the labor experience. The overall quality of the existing evidence is often described as fair to poor in systematic reviews due to methodological inconsistencies across older publications. Long-term data focusing on the effects on the neonates who were exposed during labor are not fully established or well characterized in the existing literature.


Evidence for Use in Procedural Pain and Sedation

Studies have explored the role of the gas for conscious sedation and evaluating outcomes related to physical discomfort during short medical or dental procedures. Research examined procedural completion rate, patient anxiety and distress scores, and the time required for full recovery. Study populations included both pediatric dental patients (children) and adults.

Systematic Reviews describe patterns that included frequent procedural completion in dental contexts, while noting that the measured outcomes varied across trials in other medical settings. Studies documented the short-term recovery period. However, research describes that the evidence is characterized by inconsistency in defining the specific procedural outcome measurements across various trial methodologies.


Research on Emerging Uses: Depressive Disorders

Research on Major Depressive Disorder is based on early-stage studies where the evidence remains limited. The evidence relies on early-stage Randomized Controlled Trials (RCTs) which compared varying concentrations of the gas against a placebo gas. Trials monitored how depression severity scores evolved, describing immediate but non-sustained shifts in score measurements in the hours following administration. The long-term sustained changes and the overall follow-up duration are not well characterized.

Key Studies & References

  1. Use of Nitrous Oxide for Pediatric Dental Patients (AAPD Clinical Guideline)
  2. Nitrous oxide - Electronic Essential Medicines List (WHO)

Frequently Asked Questions (FAQ)

Common questions about Nitrous Oxide (FAQ)


Q: Why is Nitrous Oxide commonly referred to as "laughing gas?"

Regulatory safety information notes that Nitrous Oxide is also known informally as 'laughing gas.' This is due to the subjective effects it can produce, which may include sensations of giddiness, mild euphoria, or excitement when inhaled during a procedure.

Q: Can Nitrous Oxide fully put a person to sleep?

Official product information notes that Nitrous Oxide as a sole agent is typically not potent enough to induce full general surgical anesthesia (deep sleep). It is most often used as an anesthetic adjunct, meaning it is combined with other stronger agents, or used alone for its strong pain-relieving and mild sedative effects while the patient remains conscious.

Q: Why is Nitrous Oxide often used in dental procedures?

Official sources cite the use of Nitrous Oxide for procedural analgesia (pain relief) and sedation. Its use is favored in short procedures, such as those in dentistry, because it offers a quick onset of effects and a swift, rapid recovery when stopped.

Q: What are the key differences between Nitrous Oxide and IV sedation?

A key pharmacological difference is Nitrous Oxide's low solubility in blood. This property ensures the gas is eliminated very quickly through the lungs once administration stops, leading to a much faster return to a normal state compared to many longer-acting intravenous (IV) sedatives.

Q: Why is pure oxygen often administered after a procedure with Nitrous Oxide?

Administering 100% oxygen is a standard part of the clinical protocol following the use of Nitrous Oxide. This step helps to counteract a phenomenon called 'diffusion hypoxia,' which is the temporary dilution of oxygen in the lungs that can occur as the gas rapidly exits the body's tissues.

Q: What is "diffusion hypoxia" and is it a risk with Nitrous Oxide?

Diffusion hypoxia is a temporary effect where the rapid out-pouring of Nitrous Oxide from the bloodstream into the lungs can momentarily dilute the amount of oxygen in the body. The risk is mitigated by the practitioner by administering 100% oxygen for a brief period post-procedure.

Q: Can children receive Nitrous Oxide during medical or dental procedures?

Regulatory documents state that the principles of safe administration, including adjusting the concentration to the patient's individual response (titration), apply across all age groups, including pediatric patients. However, its use is generally not recommended for newborns (neonates).

Q: Are there any foods or drinks to avoid before using Nitrous Oxide?

Regulatory safety information reports that common side effects include nausea and vomiting. To mitigate this risk, patients are typically advised to follow specific fasting instructions set by the practitioner prior to the procedure.

Q: Is a patient typically required to fast before receiving Nitrous Oxide?

Yes, as nausea and vomiting are documented as commonly reported side effects, patients are often advised to follow specific fasting instructions. These guidelines are put in place to reduce the risk of these effects and support patient comfort.

Q: Is it common to feel groggy or tired after the effects wear off?

Official side effect profiles list central nervous system effects such as dizziness, light-headedness, and sedation. These effects may lead to the subjective feeling of being tired or groggy in the brief period after the gas is stopped and its immediate effects have worn off.

Q: Does the gas affect fertility or breastfeeding?

The safety profile documents potential for reproductive system disruption and reduced fertility associated with prolonged or chronic exposure. For typical short-term, acute use, official guidance is not consistently specified and requires discussion within the clinical environment.

Q: How does the body naturally process and remove Nitrous Oxide?

Official pharmacological documents characterize the gas as being eliminated primarily and rapidly from the body unchanged. This removal occurs through the lungs (excretion via breathing) because of the gas's low solubility in the blood.

Q: Does Nitrous Oxide work to relieve anxiety?

Yes, official regulatory documents indicate that the gas possesses anxiolytic (anxiety-reducing) and sedative effects. This is related to its action of modulating certain inhibitory currents within the central nervous system.

Q: Can Nitrous Oxide be used during childbirth or labor?

Research evidence and official documentation note its use in obstetrical anesthesia for pain relief during labor. It is typically administered in regulated mixtures where the concentration of oxygen is kept at a high, safe level.

Q: Is Nitrous Oxide also used in emergency or trauma situations?

Official documents cite the gas’s use for the relief of severe pain, particularly in emergency settings. This includes use during short, necessary procedures like wound dressing or suturing where immediate pain management and rapid recovery are required.

Q: How quickly does Nitrous Oxide begin to work after administration?

The gas is characterized by a rapid onset of action. Due to its low blood solubility, the desired effects typically begin to be felt within 2 to 5 minutes after inhalation begins.

Q: How long do the effects of Nitrous Oxide typically last?

The effects are short-lived due to the gas’s rapid elimination from the body. Once administration is stopped, the main sensations will wear off swiftly, often within a few minutes.

Q: How long does it take for the body to eliminate Nitrous Oxide completely?

Elimination of the gas is rapid and occurs primarily through the lungs. While the immediate effects fade quickly, the gas is rapidly cleared from the body through the process of breathing.

Q: Is it normal to feel a tingling or floating sensation when using Nitrous Oxide?

Yes, official safety profiles list several common, expected effects during administration. These include subjective sensations such as pins and needles (tingling), a feeling of giddiness, or a sense of dissociation or floating.

Q: Do patients usually remember the medical procedure after using Nitrous Oxide?

The gas is known to possess amnestic properties, meaning it can cause memory loss for events occurring during the procedure. This effect is often desirable for minor procedures, particularly when higher concentrations are used.

Q: Are there any known long-term side effects from occasional, medically supervised use?

The most serious long-term side effects, such as neurological damage, are strongly linked to prolonged or repeated exposure or misuse. The official safety profile does not characterize severe long-term risk from a single, occasional, brief administration.

Q: Does Nitrous Oxide affect heart rate or blood pressure during the procedure?

Yes, official documents note the potential for temporary changes in blood pressure and heart rate. Pharmacologically, the gas is noted to possess activity that can help support blood pressure and cardiac output during the procedure.

Q: Can Nitrous Oxide cause a reaction like sweating or shivering?

Regulatory-aligned safety information lists sweating as a possible physical effect that may occur during administration. Shivering is also a recognized post-anesthetic effect following certain procedures.

Q: What are the signs that a person may have received too much Nitrous Oxide?

Regulatory sources document that over-inhalation symptoms may progress from increasing light-headedness and intoxication to more serious effects. These can include unconsciousness, a slow heart rate (bradycardia), and respiratory or cardiovascular depression.

Q: Can a patient with severe dental anxiety still receive Nitrous Oxide?

Yes, official documents confirm that the gas possesses anxiolytic properties and is specifically used to manage agitation and anxiety during procedures. It is effective for procedural sedation while the patient remains conscious and able to follow instructions.

Q: Can Nitrous Oxide be used safely if a patient has a history of substance abuse?

While a history of substance abuse is not listed as a formal contraindication, the safety profile acknowledges the possibility of psychological dependence (addiction) with non-medical or frequent use. Therefore, clinical assessment and caution are necessary.

Q: How long does the monitoring period usually last after the gas is stopped?

Due to the gas's rapid elimination, the patient is typically monitored until the effects have fully resolved and they have returned to baseline, usually requiring only a brief period of observation (e.g., a few minutes) before discharge.

Q: Can a patient drive a car immediately after receiving Nitrous Oxide?

No. Regulatory guidelines consistently recommend that patients should not drive or operate machinery for a specified period (often advised as at least 12 to 24 hours) following administration, even though the immediate effects wear off quickly.

Q: Has Nitrous Oxide been studied for use in treating depression or other mood disorders?

The overview of research evidence notes that early-stage studies have examined the use of the gas in treating Major Depressive Disorder. These trials have monitored its effects on depression severity scores.

Q: What are the specific concerns regarding high-pressure Nitrous Oxide canisters?

Official storage requirements mandate that cylinders must be protected from high heat and physical damage. Additional safety warnings highlight the risks associated with the gas's high pressure and freezing temperature, which can cause severe cold burns or other injury if misused.

Q: Is Nitrous Oxide known to be addictive?

Regulatory-aligned safety information does acknowledge that addiction (psychological dependence) can occur, particularly when the gas is used non-medically or frequently outside of controlled settings.

Q: Is there an age limit for children to receive Nitrous Oxide?

Official guidelines contraindicate the use of the gas in neonates (newborns). However, its use in older pediatric patients is generally permitted when medically necessary and when no other contraindications exist.

Q: Can Nitrous Oxide be used for pain relief in non-procedural settings?

The usage protocol officially characterizes the gas for acute and procedural use, specifically for short-term pain relief and sedation. This indicates that it is not intended for long-term or scheduled pain management in non-procedural settings.

How should Nitrous Oxide be stored and disposed of?

How to Store and Dispose of Nitrous Oxide?

Nitrous Oxide is a compressed medical gas that requires specific storage conditions and handling to maintain its stability and safety, as outlined in official regulatory documents.

Storage and Handling

Cylinders must be stored in a cool, dry, and well-ventilated area, protected from physical damage. It is prohibited to store the gas at temperatures exceeding 52 C (125 F), and the cylinders must also be protected from freezing. The cylinder must be stored upright, secured to prevent falling, and kept away from heat sources and combustible materials. The cylinder valve must remain tightly closed when not actively in use. As a mandatory safety measure, keep the product out of the sight and reach of children.

Disposal Requirements

Unused or expired Nitrous Oxide cylinders must not be disposed of in household waste. Disposal must be conducted in strict accordance with local regulations for compressed pharmaceutical waste. Consult the supplier or a qualified waste disposal company for instructions on the proper handling and discarding of the cylinder and any residual gas.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nitrous Oxide found in:

A-Z Index: